Canal Insurance CO recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
P.o. Box 7 Greenville, SC 29602
As of the latest 13F report, the guru’s equity portfolio contained 100 stocks valued at a total of $344.00Mil. The top holdings were NOC(5.58%), MSFT(5.57%), and CVS(4.72%).
According to GuruFocus data, these were Canal Insurance CO’s top five trades of the quarter.
Walmart Inc
During the quarter, Canal Insurance CO bought 50,000 shares of NYSE:WMT for a total holding of 80,000. The trade had a 1.77% impact on the equity portfolio. During the quarter, the stock traded for an average price of $138.51.
On 07/27/2022, Walmart Inc traded for a price of $125.325 per share and a market cap of $343.41Bil. The stock has returned -10.61% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Walmart Inc has a price-earnings ratio of 26.95, a price-book ratio of 4.48, a price-earnings-to-growth (PEG) ratio of 6.74, a EV-to-Ebitda ratio of 13.14 and a price-sales ratio of 0.60.
The price-to-GF Value ratio is 0.85, earning the stock a GF Value rank of 7.
GSK PLC
The guru established a new position worth 80,000 shares in MEX:GSK N, giving the stock a 1.27% weight in the equity portfolio. Shares traded for an average price of MXN1107.52 during the quarter.
On 07/27/2022, GSK PLC traded for a price of MXN849 per share and a market cap of MXN84.57Bil. The stock has returned -9.15% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, GSK PLC has a price-earnings ratio of 13.90, a price-book ratio of 4.36, a price-earnings-to-growth (PEG) ratio of 0.94, a EV-to-Ebitda ratio of 9.05 and a price-sales ratio of 1.95.
The price-to-GF Value ratio is 0.80, earning the stock a GF Value rank of 5.
Northrop Grumman Corp
Canal Insurance CO reduced their investment in NYSE:NOC by 10,000 shares. The trade had a 1.23% impact on the equity portfolio. During the quarter, the stock traded for an average price of $459.05.
On 07/27/2022, Northrop Grumman Corp traded for a price of $443.83 per share and a market cap of $68.92Bil. The stock has returned 24.19% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Northrop Grumman Corp has a price-earnings ratio of 12.26, a price-book ratio of 5.21, a price-earnings-to-growth (PEG) ratio of 0.60, a EV-to-Ebitda ratio of 9.17 and a price-sales ratio of 2.01.
The price-to-GF Value ratio is 1.18, earning the stock a GF Value rank of 3.
GSK PLC
The guru sold out of their 80,000-share investment in NYSE:GSK. Previously, the stock had a 1.2% weight in the equity portfolio. Shares traded for an average price of $45.4 during the quarter.
On 07/27/2022, GSK PLC traded for a price of $43.14 per share and a market cap of $87.63Bil. The stock has returned 12.16% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, GSK PLC has a price-earnings ratio of 14.09, a price-book ratio of 4.43, a price-earnings-to-growth (PEG) ratio of 0.95, a EV-to-Ebitda ratio of 9.14 and a price-sales ratio of 1.98.
The price-to-GF Value ratio is 1.01, earning the stock a GF Value rank of 5.
Merck & Co Inc
Canal Insurance CO reduced their investment in NYSE:MRK by 50,000 shares. The trade had a 1.13% impact on the equity portfolio. During the quarter, the stock traded for an average price of $88.55.
On 07/27/2022, Merck & Co Inc traded for a price of $90.525 per share and a market cap of $228.98Bil. The stock has returned 19.81% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Merck & Co Inc has a price-earnings ratio of 16.20, a price-book ratio of 5.60, a price-earnings-to-growth (PEG) ratio of 2.17, a EV-to-Ebitda ratio of 12.57 and a price-sales ratio of 4.26.
The price-to-GF Value ratio is 0.87, earning the stock a GF Value rank of 7.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
